Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021
The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.
In the European influenza vaccines market, Germany accounts for majority of the market share. Italy is the second leading market for influenza vaccines in 2015. United Kingdom and France are the third and fourth leading market for influenza vaccines with XX% and XX% market share in 2015. Spain accounted for XX% share of the European influenza vaccines market in 2015. Netherlands, Ireland, Denmark, Luxembourg and Sweden are the other emerging market for influenza vaccines market.
In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK’s Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.
iGATE Research report titled “Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021” provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 110 Page report contains 57 Figures and 6 Tables to present a clear picture of the influenza vaccines market.
The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Europe Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)
3. Influenza Vaccines Brand Sales and Forecast to 2021
4. Influenza Vaccines Market - Major Deals
5. Influenza Vaccines Market - Driving Factors and Challenges
Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution
1. Germany
2. France
3. Italy
4. Spain
5. United Kingdom
6. Netherlands
7. Ireland
8. Denmark
9. Luxembourg
10. Sweden
Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed
1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases
In the European influenza vaccines market, Germany accounts for majority of the market share. Italy is the second leading market for influenza vaccines in 2015. United Kingdom and France are the third and fourth leading market for influenza vaccines with XX% and XX% market share in 2015. Spain accounted for XX% share of the European influenza vaccines market in 2015. Netherlands, Ireland, Denmark, Luxembourg and Sweden are the other emerging market for influenza vaccines market.
In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK’s Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.
iGATE Research report titled “Europe Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021” provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 110 Page report contains 57 Figures and 6 Tables to present a clear picture of the influenza vaccines market.
The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Europe Influenza Vaccines Market, Persons Vaccinated and Forecast (2011 - 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)
3. Influenza Vaccines Brand Sales and Forecast to 2021
4. Influenza Vaccines Market - Major Deals
5. Influenza Vaccines Market - Driving Factors and Challenges
Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution
1. Germany
2. France
3. Italy
4. Spain
5. United Kingdom
6. Netherlands
7. Ireland
8. Denmark
9. Luxembourg
10. Sweden
Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed
1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok
Data Sources
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases
1. EXECUTIVE SUMMARY
2. EUROPE - INFLUENZA VACCINES MARKET ANALYSIS AND FORECAST (2011 - 2020)
2.1 Europe - Influenza Vaccines Market and Forecast (2011 - 2021)
2.2 Europe - Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 - 2021)
3. EUROPE - INFLUENZA VACCINES MARKET SHARE ANALYSIS AND FORECAST (2011 - 2021)
4. INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND FORECAST - COUNTRY WISE DISTRIBUTION (2011 - 2021)
4.1 Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.1.1 Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.1.2 Germany - Influenza Vaccines Market and Forecast
4.2 France - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.2.1 France - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.2.2 France - Influenza Vaccines Market and Forecast
4.3 Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.3.1 Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.3.2 Italy - Influenza Vaccines Market and Forecast
4.4 Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.4.1 Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.4.2 Spain - Influenza Vaccines Market and Forecast
4.5 United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.5.1 United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.5.2 United Kingdom - Influenza Vaccines Market and Forecast
4.6 Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.6.1 Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.6.2 Netherlands - Influenza Vaccines Market and Forecast
4.7 Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.7.1 Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.7.2 Ireland - Influenza Vaccines Market and Forecast
4.8 Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.8.1 Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.8.2 Denmark - Influenza Vaccines Market and Forecast
4.9 Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.9.1 Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.9.2 Luxembourg - Influenza Vaccines Market and Forecast
4.10 Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.10.1 Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.10.2 Sweden - Influenza Vaccines Market and Forecast
5. INFLUENZA VACCINES BRAND SALES AND FORECAST
5.1 Fluarix / FluLaval Sales and Forecast (2007 - 2021)
5.2 Fluzone Sales and Forecast (2009 - 2021)
5.3 Fluvirin/Flucelvax Sales and Forecast (2010 - 2021)
5.4 Influvac (Acquired by Abbott) Sales (2007 - 2009)
5.5 Afluria/Fluvax Sales and Forecast (2010 - 2021)
5.6 FluMist/Fluenz Sales and Forecast (2007 - 2021)
5.7 Flublok Sales and Forecast (2013 - 2021)
6. INFLUENZA VACCINES MARKET - MAJOR DEALS
6.1 Mergers and Acquisitions
6.2 Licensing Agreements
7. INFLUENZA VACCINES MARKET - DRIVING FACTORS
7.1 Transformation of Vaccine Technologies
7.2 Vaccines most Cost Effective Means of Disease Prevention
7.3 Scientific & Technological Breakthroughs
7.4 Continuous Focus on Effective Communication Strategies
7.5 Increasing Awareness on Seasonal Influenza & Vaccination
8. INFLUENZA VACCINES MARKET - CHALLENGES
8.1 Complexity of Vaccine Development and Approval System Thwarts Product Development
8.1.1 Legal Obstacles
8.1.2 General Technical Barriers
8.1.3 Economic Barriers
8.1.4 Regulatory Barriers
8.2 Hurdles to Optimal use of Licensed Vaccines
8.2.1 Technical Obstacles
8.2.2 Economic obstacles
8.2.3 Cultural Obstacles
8.3 Barriers to New Entrants in the Vaccines Market
8.4 Reducing the Timeline for Vaccine Development
8.5 Challenges Faced by Healthcare Workers in Immunization
2. EUROPE - INFLUENZA VACCINES MARKET ANALYSIS AND FORECAST (2011 - 2020)
2.1 Europe - Influenza Vaccines Market and Forecast (2011 - 2021)
2.2 Europe - Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 - 2021)
3. EUROPE - INFLUENZA VACCINES MARKET SHARE ANALYSIS AND FORECAST (2011 - 2021)
4. INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND FORECAST - COUNTRY WISE DISTRIBUTION (2011 - 2021)
4.1 Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.1.1 Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.1.2 Germany - Influenza Vaccines Market and Forecast
4.2 France - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.2.1 France - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.2.2 France - Influenza Vaccines Market and Forecast
4.3 Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.3.1 Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.3.2 Italy - Influenza Vaccines Market and Forecast
4.4 Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.4.1 Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.4.2 Spain - Influenza Vaccines Market and Forecast
4.5 United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.5.1 United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.5.2 United Kingdom - Influenza Vaccines Market and Forecast
4.6 Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.6.1 Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.6.2 Netherlands - Influenza Vaccines Market and Forecast
4.7 Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.7.1 Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.7.2 Ireland - Influenza Vaccines Market and Forecast
4.8 Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.8.1 Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.8.2 Denmark - Influenza Vaccines Market and Forecast
4.9 Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.9.1 Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.9.2 Luxembourg - Influenza Vaccines Market and Forecast
4.10 Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.10.1 Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.10.2 Sweden - Influenza Vaccines Market and Forecast
5. INFLUENZA VACCINES BRAND SALES AND FORECAST
5.1 Fluarix / FluLaval Sales and Forecast (2007 - 2021)
5.2 Fluzone Sales and Forecast (2009 - 2021)
5.3 Fluvirin/Flucelvax Sales and Forecast (2010 - 2021)
5.4 Influvac (Acquired by Abbott) Sales (2007 - 2009)
5.5 Afluria/Fluvax Sales and Forecast (2010 - 2021)
5.6 FluMist/Fluenz Sales and Forecast (2007 - 2021)
5.7 Flublok Sales and Forecast (2013 - 2021)
6. INFLUENZA VACCINES MARKET - MAJOR DEALS
6.1 Mergers and Acquisitions
6.2 Licensing Agreements
7. INFLUENZA VACCINES MARKET - DRIVING FACTORS
7.1 Transformation of Vaccine Technologies
7.2 Vaccines most Cost Effective Means of Disease Prevention
7.3 Scientific & Technological Breakthroughs
7.4 Continuous Focus on Effective Communication Strategies
7.5 Increasing Awareness on Seasonal Influenza & Vaccination
8. INFLUENZA VACCINES MARKET - CHALLENGES
8.1 Complexity of Vaccine Development and Approval System Thwarts Product Development
8.1.1 Legal Obstacles
8.1.2 General Technical Barriers
8.1.3 Economic Barriers
8.1.4 Regulatory Barriers
8.2 Hurdles to Optimal use of Licensed Vaccines
8.2.1 Technical Obstacles
8.2.2 Economic obstacles
8.2.3 Cultural Obstacles
8.3 Barriers to New Entrants in the Vaccines Market
8.4 Reducing the Timeline for Vaccine Development
8.5 Challenges Faced by Healthcare Workers in Immunization
LIST OF FIGURES:
Figure 2-1: Europe - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 2-2: Europe - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 2-3: Europe - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 2-4: Europe - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-1: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-2: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-3: Germany - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-4: Germany - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-6: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-7: France - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-8: France - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-10: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-11: Italy - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-12: Italy - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-13: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-14: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-15: Spain - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-16: Spain - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-17: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-18: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-19: United Kingdom - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-20: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-21: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-22: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-23: Netherlands - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-24: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-25: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-26: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-27: Ireland - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-28: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-29: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-30: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-31: Denmark - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-32: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-33: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-34: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-35: Luxembourg - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-36: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-37: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-38: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-39: Sweden - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-40: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 5-1: Global - Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007 - 2015
Figure 5-2: Global - Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-3: Global - Fluzone Influenza Vaccine Sales (Million US$), 2009 - 2015
Figure 5-4: Global - Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-5: Global - Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2009 - 2015
Figure 5-6: Global - Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-7: Global - Influvac Influenza Vaccine Sales (Million US$), 2007 - 2009
Figure 5-8: Global - Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010 - 2015
Figure 5-9: Global - Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-10: Global - FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007 - 2015
Figure 5-11: Global - Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-12: Global - Flublok Influenza Vaccine Sales (Million US$), 2013 - 2015
Figure 5-13: Global - Forecast for Flublok Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 2-1: Europe - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 2-2: Europe - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 2-3: Europe - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 2-4: Europe - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-1: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-2: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-3: Germany - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-4: Germany - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-5: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-6: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-7: France - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-8: France - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-9: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-10: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-11: Italy - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-12: Italy - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-13: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-14: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-15: Spain - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-16: Spain - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-17: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-18: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-19: United Kingdom - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-20: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-21: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-22: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-23: Netherlands - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-24: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-25: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-26: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-27: Ireland - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-28: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-29: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-30: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-31: Denmark - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-32: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-33: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-34: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-35: Luxembourg - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-36: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 4-37: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2015
Figure 4-38: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2016 - 2021
Figure 4-39: Sweden - Influenza Vaccines Market (Million US$), 2011 - 2015
Figure 4-40: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2016 - 2021
Figure 5-1: Global - Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007 - 2015
Figure 5-2: Global - Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-3: Global - Fluzone Influenza Vaccine Sales (Million US$), 2009 - 2015
Figure 5-4: Global - Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-5: Global - Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2009 - 2015
Figure 5-6: Global - Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-7: Global - Influvac Influenza Vaccine Sales (Million US$), 2007 - 2009
Figure 5-8: Global - Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010 - 2015
Figure 5-9: Global - Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-10: Global - FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007 - 2015
Figure 5-11: Global - Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2016 - 2021
Figure 5-12: Global - Flublok Influenza Vaccine Sales (Million US$), 2013 - 2015
Figure 5-13: Global - Forecast for Flublok Influenza Vaccine Sales (Million US$), 2016 - 2021
LIST OF TABLES:
Table 3-1: Country Wise - Influenza Vaccines Market Share (Percent), 2011 - 2015
Table 3-2: Country Wise - Forecast for Influenza Vaccines Market Share (Percent), 2016 - 2021
Table 6-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2015
Table 6-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2015
Table 7-1: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations
Table 7-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Table 3-1: Country Wise - Influenza Vaccines Market Share (Percent), 2011 - 2015
Table 3-2: Country Wise - Forecast for Influenza Vaccines Market Share (Percent), 2016 - 2021
Table 6-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2015
Table 6-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2015
Table 7-1: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations
Table 7-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
